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ABSTRACT 
BACKGROUND: the emergency due to SARS-CoV-2 pan-
demic struck the national and regional health system that 
needed an effort to reorganise and increase resources to 
cope with a sudden, uncertain, and previously unknown situ-
ation. This study was conducted in the immediate aftermath 
of this difficult period.
OBJECTIVES: to describe clinical characteristics, short-term 
outcomes, and management of SARS-CoV-2 positive pa-
tients that accessed the emergency department (ED) of the 
San Luigi Gonzaga hospital of Orbassano (Turin district, Pied-
mont Region, Northern Italy) in March and April 2020. Fur-
thermore, this study aimed at investigating if a difference in 
patients characteristics, clinical management, and outcomes 
was present during time. 
DESIGN: comparison of different periods in a clinical cohort.
SETTING AND PARTICIPANTS: for each patient who ac-
cessed the ED and tested positive for SARS-CoV-2 swab, the 
ED medical record was collected and a descriptive analysis 
was performed on demographical characteristics, pre-exist-
ing comorbidities, parameters measured at triage, imaging 
exams results, lab tests results, separately for patients admit-
ted at the ED in four different periods.
MAIN OUTCOME MEASURES: discharge from ED, admis-
sion to hospital wards (low and high intensity of care), short 
term in-hospital mortality, hospital length of stay. The asso-
ciation between patients’ characteristics and the main out-
comes was measured using multivariable logistic models.
RESULTS: age of patients increased significantly from March 
to April, together with female prevalence and associated co-
morbid conditions. A significant difference in symptoms at 
presentation was not observed nor it was in laboratory test 
results. Severity at triage and need of intensive care resourc-
es were higher in the first weeks, together with the typical 
clinical presentation with respiratory failure and imaging with 
signs of bilateral interstitial pneumonia. Accordingly, in-hos-
pital mortality was higher in the first period. Nevertheless, 
nearly half of patients in the first period were discharged di-
rectly from ED showing mild COVID-19 cases. On the contra-
ry, in April an increasing need of hospitalisation in low inten-
sity of care beds was observed, whereas mild cases stopped 
to access the ED. 
CONCLUSIONS: the results of this study suggest that in few 
weeks of COVID-19 epidemic both management of the pa-
tients at the hospital level – and probably at territorial level re-
sulting in a different population who accessed to the ED – and 
the clinical characteristics of the COVID-19 patients changed. 
Keywords: COVID-19, hospital management, emergency department, 
in-hospital mortality
RIASSUNTO 
INTRODUZIONE: l’emergenza dovuta alla pandemia di 
SARS-CoV-2 ha colpito il sistema sanitario nazionale e regio-
nale, che ha dovuto riorganizzarsi e aumentare le risorse per 
fare fronte a una situazione improvvisa, incerta e nuova.
OBIETTIVI: descrivere le caratteristiche cliniche, gli outcome 
a breve termine e la gestione dei pazienti positivi al SARS-
CoV-2 che hanno avuto un accesso al pronto soccorso (PS) 
dell’ospedale San Luigi Gonzaga di Orbassano (TO) nei mesi 
di marzo e aprile 2020 e valutare se vi sia stata una differen-
za temporale nelle caratteristiche dei pazienti, nella gestione 
clinica e nei loro outcome. 
DISEGNO: confronti di diversi periodi temporali in una co-
orte clinica. 
WHAT IS ALREADY KNOWN
Q SARS-CoV-2 pandemic struck the national and region-
al health system that needed an effort to reorganise and 
increase resources to cope with a sudden, uncertain, and 
previously unknown situation.
Q Differences in clinical presentation during the pan-
demic period have been observed in China and a study 
identified a novel SARS-CoV-2 mutation in Europe.
WHAT THIS STUDY ADDS
Q During the first two months of emergency in Pied-
mont Region (Northern Italy), there was a change over 
time in type of COVID-19 patients accessing to the emer-
gency department of a regional hospital, who became 
older and with a more severe COVID-19 syndrome.
Q During the first two months of emergency in Pied-
mont Region, outcomes of COVID-19 patients improved 
over time with less needs of high intensity of care.
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INTRODUCTION
On January 9th 2020, the World Health Organisation 
(WHO) declared the identification of a new Coronavi-
rus responsible for severe pneumonias in China, and clas-
sified it as SARS-CoV-2. This virus is the cause of a respir-
atory disease that was called ‘COVID-19’. The first two 
cases in Italy were identified on February 19th and, from 
then on, a wave of the pandemic outbreak occurred, with 
232,997 confirmed infected cases and 33,415 deaths at 
the end of May.1
The Piedmont (a Region located in Northern Italy with a 
population of about 4 million inhabitants) is the second re-
gion in Italy for number of cases (more than 30,000 at the 
end of May, cumulative incidence: 703.26 per 100,000) 
and the epidemic curve raised dramatically after the 15th 
of March, with over 400 new infected subjects per day un-
til the end of April,2 as shown in figure 1. 
Patients with COVID-19 complain of cough, diarrhoea, 
nausea, vomiting, fever, headache, sore throat, anosmia, 
ageusia, weakness, and dyspnoea;3,4 SARS-CoV-2 infec-
tion is confirmed through nasopharyngeal and/or oro-
pharyngeal swabs. While the majority of cases proceed 
with a benign or mild clinical course, some develop inter-
stitial pneumonia with severe respiratory failure and need 
of intensive care resources. 
At the beginning of the pandemic, swabs were mainly per-
formed at the emergency departments (EDs) where symp-
tomatic patients arrived without a previous contact with 
the National Health System. After few weeks, the imple-
mentation of new tasks for several health local services let 
part of COVID-19 suspected patients to be managed di-
rectly at their home.5 
Differences in clinical presentation during the pandemic 
period have been observed in China6 and a study identified 
a novel SARS-CoV-2 mutation in Europe, leaving room for 
the hypothesis that the virus is also evolving during time.7 
Moreover, a gradual improvement of therapeutic plans im-
proved patients’ outcomes during time8 and the contain-
ment measures differently applied by each country may 
have changed patients’ sociodemographic characteristics.
The aim of this study was to investigate if clinical charac-
teristics, short-term outcomes, and management of SARS-
CoV-2 positive patients that accessed the ED of the San 
Luigi Gonzaga hospital changed over time from March to 
April 2020.
MATERIALS AND METHODS
In this study, all SARS-CoV-2 positive patients that acced-
ed to the ED of the San Luigi Gonzaga hospital in Orbassa-
no (TO), Italy, from the 1st March to the end of May 2020 
were retrospectively recruited. Due to the small number of 
infected cases acceded to the hospital in May (a total of 5 
patients), the analyses were restricted to patients recruited 
in the first two months of the study.
For each patient, the ED digital medical record with data 
regarding medical history, clinical presentation, symptoms, 
diagnostic tests (blood tests, imaging), treatment, and res-
piratory support performed in the ED was obtained.
The study was approved by the hospital ethical commit-
tee (protocol 5257 01.04.2020) and was conducted in line 
with the Helsinki declaration. 
STATISTICAL ANALYSIS
A descriptive analysis was performed on demographic char-
acteristics, pre-existing comorbidities, parameters meas-
ured at triage, imaging exams results, lab tests results, and 
outcome from ED (discharge or not discharge), separate-
ly for patients admitted at the ED in four different periods 
(1st-15th March, 16th-31st March, 1st-15th April, 16th-30th 
April 2020). Continuous variables were expressed as me-
dian and interquartile range (IQR), categorical variables as 
frequencies and percentages. 
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STUDI E RIFLESSIONI DELL’EPIDEMIOLOGIA ITALIANA 
NEL PRIMO SEMESTRE DELLA PANDEMIA
SETTING E PARTECIPANTI: sono state raccolte le cartelle cli-
niche di tutti i pazienti che hanno avuto un accesso in PS e il 
cui tampone è risultato positivo per SARS-CoV-2. Le caratte-
ristiche demografiche, le comorbidità preesistenti, i parame-
tri misurati al triage, i risultati degli esami diagnostici e i risul-
tati dei test di laboratorio sono stati descritti separatamente 
per quattro periodi temporali. 
PRINCIPALI MISURE DI OUTCOME: dimissione dal PS, tipo 
di reparto di trasferimento (a bassa o alta intensità di cura), 
mortalità intraospedaliera a breve termine, lunghezza del ri-
covero. L’associazione tra caratteristiche dei pazienti e i prin-
cipali outcome è stata misurata utilizzando modelli di regres-
sione logistica multivariati.
RISULTATI: l’età dei pazienti è aumentata tra marzo e apri-
le, così come la prevalenza di donne e le comorbidità asso-
ciate. Non si è osservata una differenza di sintomi all’accetta-
zione o di risultati dei test di laboratorio. La gravità clinica al 
triage e il bisogno di intensità delle cure sono stati più eleva-
ti nelle prime settimane, così come la presentazione clinica di 
insufficienza respiratoria e gli esami diagnostici con segni di 
polmonite interstiziale bilaterale. Concordemente, la morta-
lità intraospedaliera è stata più alta nel primo periodo. Tutta-
via, circa metà dei pazienti del primo periodo è stata dimes-
sa dal PS senza ricovero in quanto casi lievi di COVID-19. Al 
contrario, in aprile è aumentato il numero dei ricoverati, an-
che se in reparti a bassa intensità, mentre vi è stata una dimi-
nuzione di accessi in PS dei casi lievi. 
CONCLUSIONI: i risultati dello studio suggeriscono che nelle 
prime settimane di pandemia di SARS-CoV-2 sono cambiate 
sia le procedure di gestione dei pazienti a livello ospedaliero 
– e, probabilmente, anche sul territorio, come suggerito dal-
la differente popolazione che ha avuto accesso al PS – sia le 
caratteristiche cliniche e anagrafiche dei pazienti COVID-19.
 
Parole chiave: COVID-19, gestione ospedaliera, pronto soccorso, 
mortalità ospedaliera
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Kruskal-Wallis was used in order to analyse differences in 
distribution of continuous variables through the four pe-
riods, Fisher’s Exact and chi2 tests were used to compare 
categorical variables through the four periods where ap-
propriate.
Multivariable logistic regressions have been performed to 
estimate the odds ratio (OR) of the admission periods (ref-
erence period: the first two weeks of March) on the ED 
outcome (discharge or not discharge), considering pa-
tients’ age, gender, and comorbidities.
Additional analyses have been conducted on the subgroup 
of  hospitalised patients, describing and evaluating the dif-
ferences in hospital wards, length of stay, and in-hospital 
mortality separately for the four periods. 
Furthermore, in  hospitalised patients, multivariable logis-
tic regressions of the admission periods adjusting by pa-
tients’ age, gender, and comorbidities have been performed 
considering two different outcomes:
1. admission in different level of care wards: intensive care 
unit (ICU) and high dependency unit (HDU) vs internal 
medicine ward;
2. in hospital mortality.
All the analyses were performed using R software (version 
3.6.2). Statistical confidence level was fixed considering a 
first type error alpha equal to 0.05.
RESULTS
Among 2,450 patients admitted in the ED from the begin-
ning of March till the end of April 2020, 1,027 (42%) un-
derwent a nasopharyngeal swab: 224 (9%) patients result-
ed positive to SARS-CoV-2 and were included in this study.
Table 1 shows the demographic characteristics of the pa-
tients according to the four calendar periods. The num-
ber of ED visits by patients who tested positive changed 
over time, with a peak at the end of March. The age of the 
patients increased significantly (p<0.001) over time from 
a median age lower than 60 years in the first period to a 
median age above 80 years in the end of April. The gen-
der distribution of patients changed over time (p=0.017): 
the percentage of males, initially larger (63.3%) than the 
percentage of females (36.7%), decreased during the first 
three periods and they were overturned at the first period 
of April (64.1% of females and 35.9% of males). Nearly 
15% of patients were health professionals.
Table 2 shows the characteristics of the patients included in 
the study regarding:
Q comorbidities and previous chronic conditions;
Q triage parameters;
Q diagnostic imaging exams;
Q laboratory tests;
Q symptoms;
Q emergency department outcomes.
Nearly half of patients in the first two periods were affect-
ed by hypertension, while prevalence of hypertension in-
creased to 60% in the last two periods.
Interestingly, the prevalence of previous chronic conditions 
(always higher than 65%) changed over time (p=0.017), 
reaching the totality of patients in the last period. Accord-
ingly, the Charlson comorbidity index (CCI) significantly 
increased over time (p=0.009), mainly consisted of cere-
brovascular diseases, solid tumours, and a significantly in-
crease of dementia.
A statistically significant difference of the triage evaluation 
over time was observed (p=0.041): around 65% of patients 
received an immediate/urgent evaluation both in the first 
and in the last period, while more than half of the patients 
admitted between 16th March and 15th April received a de-
layed/expectant evaluation. Among patients evaluated im-
mediate/urgent at triage, the Fisher’s exact test highlighted a 
significant different distribution of ED discharge (p<0.001) 
and respiratory support (p <0.001) over time: indeed, more 
than half of the patients evaluated as immediate/urgent at 
triage in the first period were then discharged from ED 
(56%) and without any respiratory support (63%), while 
almost all of those evaluated as urgent in the last three pe-
riods died or were admitted to hospital (96%, 93%, and 
100%, respectively) and furthermore received a respiratory 
support (31%, 65%, 82%).
The median values of PaO2/FiO2 show that this parameter 
was out of the normal range in at least half of the patients 
in each period. According to the decline of oxygen satura-
tion, respiratory supports have been provided differently 
over time (p=0.007), above all in the last period (76.5% 
of the patients). 









No. (%) No. (%) No. (%) No. (%) No. (%)
No.                                               30 113 64 17
AGE                        56.7 [47.3;73.4] 59.8 [48.9;75.8] 73.0 [58.4;83.0] 80.1 [72.8;89.1] <0.001#
GENDER
Male 19 (63.3) 66 (58.4) 23 (35.9) 8 (47.1)
0.017°
Female 11  (36.7) 47 (41.6) 41 (64.1) 9 (52.9)
HEALTHCARE  
EMPLOYEE
No 28 (93.3) 97 (85.8) 50 (78.1) 15  (88.2)
0.279§
Yes 2 (6.7) 16 (14.2) 14 (21.9) 2 (11.8)
# Kruskal-Wallis test / test di Kruskal-Wallis   ° Chi2 test / test del chi2   § Fisher’s exact test / Test esatto di Fisher   IQR: Interquartile Range / range interquartile
Table 1. Demographical characteristics of the sample.
Tabella 1. Caratteristiche demografiche del campione.
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COMORBIDITIES AND PREVIOUS CHRONIC CONDITIONS
HYPERTENSION
No  13 (54.2)  52 (52.5)  21 (39.6)  5 (35.7)
0.329§
Yes  11 (45.8)  47 (47.5)  32 (60.4)  9 (64.3)
OBESITY
BMI<30 kg/m2  29 (96.7)  101 (89.4)  61 (95.3)  15 (88.2)
0.382§
BMI*30 kg/m2  1 (3.3)  12 (10.6)  3 (4.7)  2 (11.8)
PREVIOUS 
CHRONIC 
CONDITIONS       
No  6 (21.4)  37 (33.0)  17 (27.0)  0 (0.0)
0.017§
Yes  22 (78.6)  75 (67.0)  46 (73.0)  17 (100.0)
CCI 0.0 [0.0;2.0] 0.0 [0.0;2.0] 1.00 [0.0;2.0] 2.00 [1.0;3.0] 0.009#
COMORBIDITIES
none  20 (66.7)  68 (60.2)  37 (57.8)  7 (41.2)
0.316§one  6 (20.0)  27 (23.9)  20 (31.2)  4 (23.5)




delayed/expectant  8 (33.3)  66 (59.5)  37 (57.8)  6 (35.3)
0.041°
immediate/urgent  16 (66.7)  45 (40.5)  27 (42.2)  11 (64.7)
TEMPERATURE
<37  9 (40.9)  38 (36.2)  25 (39.7)  9 (56.3) 
0.125§37-37.5  1 (4.5)  18 (17.1)  17 (27.0)  1 (6.3)
*37.5  12 (54.6)  49 (46.7)  21 (33.3)  6 (37.5)
PAO2/FIO2 (mmHg) Normal range 350-400 352.4 [276.1;395.2] 331.0 [248.8;409.5] 328.6 [271.4;385.7] 283.3 [221.4;327.4] 0.371#
RESPIRATORY 
SUPPORT
No  19 (67.9)  46 (43.0)  36 (58.1)  4 (23.5) 0.007§




Consolidation  0 (0.0)  2 (2.1)  1 (2.1)  0 (0.0)
Irregular pleural line  0 (0.0)  1 (1.1)  0 (0.0)  0 (0.0)
Focal B lines  1 (4.5)  12 (12.8)  4 (8.3)  0 (0.0)
Multiple b lines (“light beam”)  5 (22.7)  29 (30.9)  8 (16.7)  3 (25.0)
Pleural effusion  0 (0.0)  0 (0.0)  2 (4.2)  2 (16.7)
Normal lung ultrasound scan    16 (72.7)  50 (53.2)  33 (68.8)  7 (58.3)
X-RAY 
RESULTS
Pneumonia  6 (23.1)  19 (17.9)  12 (21.1)  4 (25.0)
Bilateral pneumonia  4 (15.4)  41 (38.7)  16 (28.1)  6 (37.5)
Normal  16 (61.5)  46 (43.4)  29 (50.9)  6 (37.5)
CT RESULTS
Focal ground glass lesion  0 (0.0)  0 (0.0)  0 (0.0)  1 (14.3)
Bilateral ground glass lesions                0 (0.0)  0 (0.0)  1 (12.5)  2 (28.6)
Diffuse ground glass lesions  0 (0.0)  1 (33.3)  0 (0.0)  1 (14.3)
Consolidation  0 (0.0)  1 (33.3)  0 (0.0)  0 (0.0)
Normal CT scan                                         1 (100.0)  1 (33.3)  7 (87.5)  3 (42.9)
LAB TESTS
WHITE BLOOD CELL (K/µL)            5.9 [4.2;6.8] 6.0 [4.7;8.0] 5.7 [4.6;8.3] 8.1 [5.2;11. 5] 0.273#
C-REACTIVE PROTEIN (mg/dL)              1.6 [0.5;6.9] 4.8 [1.4;11.4] 6.3 [1.5;11.6] 8.9 [2.7;15.8] 0.061#
PROCALCITONIN (ng/mL)        0.06 [0.04;0.08] 0.09 [0.04;0.21] 0.08 [0.05;0.18] 0.10 [0.05;0.42] 0.349#
LDH (U/L) 241.5 [174.0;349.5] 343.0 [219.5;460.5] 329.0 [225.5;411.5] 315.5 [269.3;507.8] 0.035#
LDH
<243 (U/L)  12 (50.0)  29 (28.2)  17 (33.3)  4 (25.0)
0.212§
*243 (U/L)  12 (50.0)  74 (71.8)  34 (66.7)  12 (75.0)
PLATELETS (%)  178.0 [131.0;217.8] 193.0 [148.0;237.0] 185.0 [166.8;240.5] 198.0 [188.3;296.5] 0.326#
LYMPHOCYTES (KµL)   1.14 [0.98;1.81] 1.12 [0.70;1.48] 1.08 [0.82;1.38] 1.20 [0.86;1.55] 0.481#
LYMPHOCYTES 
)0.9 (KµL)                            6 (24.0)  42 (38.5)  22 (36.7)  6 (37.5)
0.787§0.9-5.2 (KµL)                     19 (76.0)  65 (59.6)  36 (60.0)  10 (62.5)
*5.2 (KµL)                                  0 (0.0)  2 (1.8)  2 (3.3)  0 (0.0)
SYMPTOMS
COUGH
No  8 (30.8)  41 (39.0)  17 (31.5)  11 (64.7)
0.081°
Yes  18 (69.2)  64 (61.0)  37 (68.5)  6 (35.3)
DYSPNOEA
No  14 (56.0)  40 (39.6)  28 (54.9)  8 (47.1)
0.232°




No  21 (84.0)  84 (84.0)  36 (81.8)  16 (94.1)
0.743§
Yes  4 (16.0)  16 (16.0)  8 (18.2)  1 (5.9)
FEVER
No  4 (16.0)  18 (17.1)  8 (13.1)  4 (23.5)
0.747§
Yes  21 (84.0)  87 (82.9)  53 (86.9)  13 (76.5)
HEADACHE
No  25 (100.0)  96 (96.0)  41 (93.2)  17 (100.0)
0.552§
Yes  0 (0.0)  4 (4.0)  3 (6.8)  0 (0.0)
SORE THROAT
No  22 (84.6)  87 (84.5)  41 (83.7)  17 (100.0)
0.365§
Yes  4 (15.4)  16 (15.5)  8 (16.3)  0 (0.0)
EMERGENCY DEPARTMENT OUTCOMES
DISCHARGED  14 (46.7)  39 (34.5)  19 (29.7)  1 (5.9)
0.025§
NOT DISCHARGED  16 (53.3)  74 (65.5)  45 (70.3)  16 (94.1)
# Kruskal-Wallis test / test di Kruskal-Wallis    ° Chi2 test / test del chi2    § Fisher’s exact test / Test esatto di Fisher    BMI: body mass index / indice di massa corporea    IQR: Interquartile Range / range 
interquartile    CCI: Charlson Comorbidity Index / indice di comorbidità di Charlson    CT: computed tomography / tomografia computerizzata    LDH: lactate dehydrogenase / lattato deidrogenasi
Table 2. Characteristics of patients admitted at emergency department between March 1st and April 30th 2020. 
Tabella 2. Caratteristiche dei pazienti accettati in pronto soccorso tra il 1° marzo e il 30 aprile.
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As suggested by national guidelines, ultrasound and x-ray 
have been mainly performed at arrival in ED, more than 
70% and 85%, respectively, in each period, while CT has 
been performed just in atypical presentations, in case of 
uncertainty or complicated situations. Typical lung ultra-
sound patterns were observed, previously described9 as 
multiple B lines with light beam or pleural irregularity, 
mainly in the first two periods, whereas pleural effusion 
was present in a minority of cases. More than half of the 
patients had a negative ultrasound: the percentage of neg-
ative and atypical ultrasound findings (focal B lines, con-
solidation and pleural effusion) increased in the last two 
periods. X-ray exams showed unilateral or bilateral pneu-
monia, resulting positive in about half of the patients.
Examining laboratory test results, an inflammatory state 
was observed in many patients affected by COVID-19: C-
reactive protein median values were always out of the nor-
mal and increased over time (p=0.061). Similarly, LDH 
median values changed over time (p=0.035) and were al-
most always higher than the normality threshold, meaning 
that more than half of the patients had values out of the 
norm, as well as it occurred for procalcitonin.
All the patients admitted to the ED were symptomatic 
and symptoms did not significantly change over time. The 
symptoms most commonly reported were dyspnoea and 
cough. In addition, 83.6% of subjects reported fever in 
the previous days.
A total of 73 patients were discharged (quarantined at home 
in isolation), while 151 patients were admitted to another 
hospital ward (No. 147) or transferred to another hospital 
(No. 2) or died at the ED (No. 2). The number of patients 
transferred to their own home significantly decreased over 
time (p=0.025), being almost abated in the last period.
Details for hospitalised patients after ED are presented 
in table 3. Nearly half of them were admitted to HDU 
(37%) and ICU (19%) in the first period. The admission 
in HDU was still 44% in the second period, then signifi-
cantly decreased (p=0.038). Accordingly, deaths during the 
hospitalisation decreased over time, except for the last peri-
od and the length of stay for hospitalised people decreased 
from a median of 27 days in the first period to 15 days in 
the last one.
In table 4 and 5 results from multivariable logistic regres-
sion analyses are presented for short-term outcome (dis-
charge from ED) and medium-term outcomes (admission 
to ICU or HDU and death during hospitalisation), respec-
tively. The models confirmed the results observed in uni-
variate analyses, showing that over time hospitalisations of 
COVID-19 patients increased; nonetheless, hospitalised 
patients obtained more favourable outcomes.
DISCUSSION
After China, Italy was the second most affected country 
in the first months of SARS-CoV-2 pandemic10 and the 
Italian National Health System was one of the most in-
volved in responding to the immediate health care needs at 
the beginning of this emergency. EDs, together with pre-
hospital emergency systems, had to define new pathways 
and to create new protocols to warrant timely and effec-
tive care for the affected individuals and to limit spread of 
the disease on health care providers/hospital staff and on 
other inpatients. The whole health system needed to re-
organise out-of-hospital resources and to create addition-
al surge capacity especially for Intensive Care Resources 
(ICU beds, ventilators, Continuous Positive Airway Pres-
sure – CPAP) and for personal protective equipment sup-
ply. The relative novelty of this clinical syndrome, the un-
certainties in management and in containment measures 
and many controversial information added confusion to 
the entire process.11 In the experience of the authors on 
the field, a difference was perceived between the first weeks 
and the following period, but evidence is lacking and only 
hypotheses have been made about a change in virulence or 
the effect of lock-down measures. Thus, this study aimed 
to evaluate in a systematic way these impressions trying 
to identify a trend in the SARS-CoV-2 epidemic timeline.
In this scenario, at least in the first weeks of outbreak, the 
ED served not only as a first line resource for acute patient 
care, but also as a support for the Italian National Health 
Service to identify new cases and as a safety-net for gen-
eral practitioners (GPs) until a synergic coordinated sys-
tem was available. The findings of the present study are in 
line with these considerations: the number of cases admit-
ted to ED increased in March, reaching the peak of num-













NUMBER 16 73 44 16
HOSPITAL WARD
internal medicine  7 (43.8)  39 (53.4)  32 (74.4)  11 (68.8)
0.038§sub intensive care  6 (37.5)  32 (43.8)  10 (23.3)  5 (31.2)
intensive care  3 (18.8)  2 (2.7)  1 (2.3)  0 (0.0)
DEATH
No  9 (56.2)  46 (63.0)  32 (72.7)  9 (56.2)
0.509°
Yes  7 (43.8)  27 (37.0)  12 (27.3)  7 (43.8)
LENGTH OF STAY (DAYS) 27.0 [13.3;46.5] 17.0 [8.0;27.0] 16.0 [7.5;25.5] 15.00 [9.0;24.5] 0.172#
# Kruskal-Wallis test / test di Kruskal-Wallis      ° Chi2 test / test del chi2      § Fisher’s exact test / Test esatto di Fisher
Table 3. Characteristics of hospitalized patients.
Tabella 3. Caratteristiche dei pazienti ospedalizzati.
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 OR (95%CI) P-VALUE
ADMISSION PERIOD
16th-31st March vs 1st-15th March 2.15 (0.71-6.66) 0.176
1st-15th April vs 1st-15th March 1.38 (0.38-4.99) 0.622
16th-30th April vs 1st-15th March 6.06 (0.62-144.20) 0.163
AGE 1.11 (1.07-1.15) <0.001
GENDER female vs male 0.41 (0.18-0.90) 0.029
CCI 1.49 (1.04-2.33) 0.051
OR: Odds ratio / odds ratio      CCI: Charlson Comorbidity Index / indice di comorbidità di Charlson
Table 4. Multivariable logistic regression of the admission period to emergency department on the short-term outcome (not discharged versus discharged from emer-
gency department).





16th-31st March vs 1st-15th March 0.58 (0.17-1.90) 0.375
1st-15th April vs 1st-15th March 0.34 (0.08-1.29) 0.117
16th-30th April vs 1st-15th March 0.59 (0.12-2.83) 0.517
AGE 0.97 (0.94-0.99) 0.022
GENDER female vs male 0.61 (0.28-1.32) 0.210
CCI 0.79 (0.62-0.98) 0.041
B
ADMISSION PERIOD
16th-31st March vs 1st-15th March 0.67 (0.19-2.37) 0.528
1st-15th April vs 1st-15th March 0.24 (0.06-0.97) 0.047
16th-30th April vs 1st-15th March 0.40 (0.08-1.99) 0.268
AGE 1.08 (1.05-1.13) <0.001
GENDER female vs male 0.74 (0.32-1.68) 0.475
CCI 1.12 (0.91-1.39) 0.275
OR: Odds ratio / odds ratio      CCI: Charlson Comorbidity Index / indice di comorbidità di Charlson
Table 5. (A) Multivariable logistic regression of the admission period to Emergency Department on the first medium-term outcome (subintensive or intensive care unit 
admission versus internal medicine ward admission, among hospitalized patients); (B) Multivariable logistic regression of the admission period to Emergency Department 
on the second medium-term outcome (death during hospitalization, among hospitalized patients).
Tabella 5. (A) Regressione logistica multivariata rispetto al primo outcome a medio termine (ricovero in terapia intensiva o subintensiva versuvss ricovero in reparto 
di medicina, nei pazienti ospedalizzati); (B) Regressione logistica multivarariata rispetto al secondo outcome a medio termine (morte durante l’ospedalizzazione, nei 
pazienti ospedalizzati).
Figure 1. Number of SARS-CoV-2 infected cases from 1st of March to 31st of May, Piedmont Region (Northern Italy). Data retrieved from Civil Defence database (avai-
lable from: https://github.com/pcm-dpc/COVID-19/blob/master/dati-regioni/dpc-covid19-ita-regioni.csv).
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ber of admitted patients in the second part of March, even 
if patients admitted to ED in the first two weeks of March 
were younger, presented with mild symptoms, according 
both to the laboratory tests results and imaging features, 
and with a higher probability to be discharged at home af-
ter the ED access.
The second period of March was characterized by a con-
siderable afflux of relatively young patients in their fif-
ties, mainly affected by interstitial pneumonia with typical 
findings at chest X-ray and lung ultrasound, with an im-
portant rise in infection markers and lactic dehydrogenase 
levels. Nearly half of patients needed respiratory support, 
suggesting that their health status was poorer than the one 
of the patients in the first period. However, the perceived 
severity expressed by triage evaluation was similar to those 
arriving at the beginning of the month, suggesting that the 
first cases could have been over-triaged because of the nov-
elty of the situation. This is in line with the experience of 
Lombardy Region and it is common in all healthcare sys-
tems where the emergency system is used to rapid turno-
ver and prepared to increase its capacity to cope with un-
expected events.12 
The majority of published data in China, Italy, and USA 
focused on the first month of outbreak;13-15 however, in 
the data here presented, the characteristics of patients ad-
mitted in ED changed drastically after the first two weeks 
of outbreak. In April, the number of COVID-19 admit-
ted to ED progressively decreased, whereas the age of the 
patients increased significantly (p<0.001). Similar results 
were observed by Petrilli et al. in the City of New York 
with a shift of two weeks, due to the different pandemic 
period in Italy and USA,16 and it is probably in part due 
to the outbreaks identified in residential care homes.
The change in number of patient’s admission in March and 
April only partially reflects the trend of outbreak in Pied-
mont Region (figure 1) that, after the increase in the sec-
ond part of March, still increased in the first part of April 
and decreased more slowly in the last observed period. This 
fact, together with the lower percentage of discharged pa-
tients after ED visit, suggests that a different organisation 
of COVID-19 patient care was effective in Piedmont, both 
from National Health Service and GPs. In fact, a reduction 
of inappropriate accesses of patients with mild symptoms 
was observed, suggesting a better management at GPs level. 
With regard to demographic distribution, a male preva-
lence was observed also in this study, similarly to previ-
ous findings.17 Interestingly, this pattern was overturned in 
the last two periods in April, after public health measures 
of containment were applied in Piedmont Region, reduc-
ing the spread of the disease in the active adult population. 
In fact, after the application of lockdown measures, the 
SARS-CoV-2 outbreaks were mainly among health profes-
sionals and residents of residential care homes.
This change in population characteristics is also evident 
looking at comorbidities at the moment of admission. In 
fact, as expected, the number of patients presenting one or 
more comorbidities increased overtime together with the 
increase in median age.
The patients admitted in the month of April were impos-
sible to treat as out-patients, because they were older, with 
several comorbid conditions, and showed altered labora-
tory tests and higher need of respiratory support than pa-
tients previously assisted. Anyway, they appeared to have 
less typical findings of COVID-19 pneumonia at first lev-
el imaging.
Regarding patients’ outcomes, the admission in HDU was 
higher in the month of March (almost a half of patients) 
and then decreased, while an increase in medical wards 
(low intensity of care wards) was observed in the last two 
periods. Furthermore, even if older patients with a high-
er prevalence of comorbidities were admitted, a decrease 
in the access to the ICU and in the length of stay for hos-
pitalised people was evident. Mortality tended to decrease 
during the hospitalisation, except for the last period (16th-
30th April). Petrilli et al.16 showed that in New York critical 
illness and mortality decreased over time. They advocat-
ed an improvement in outcomes over time due to famili-
arity with the disease, ongoing iteration of protocols and 
practices in response to observed outcomes, and initiation 
of new treatments. Similarly in Piedmont Region, an im-
provement in diagnostic path, outpatients healthcare reor-
ganisation, and improvement in guidelines for therapy and 
hospital care for COVID-19 patients was observed during 
outbreak period.18,19
The main limitation of this study is the limited sample 
size composed of patients recruited in a single hospital in 
the province of Turin. However, it is likely that the con-
secutive collection of all patients admitted to the ED in 
the reference hospital of a large area of the province is rep-
resentative at least of the Regional management of the 
SARS-CoV-2 epidemic.
In conclusion, the results of this study suggest that in few 
weeks of COVID epidemic changed the management of 
the COVID-19 patients at the hospital level and probably 
at territorial level, resulting in a different population who 
accessed to the ED both from baseline characteristics and 
clinical outcomes.
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